• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脂蛋白仿生纳米结构通过巨胞饮作用实现 siRNA 对 Ras 激活的神经胶质瘤细胞的高效靶向递送。

Lipoprotein-biomimetic nanostructure enables efficient targeting delivery of siRNA to Ras-activated glioblastoma cells via macropinocytosis.

机构信息

Department of Pharmacology, Institute of Medical Sciences, Shanghai Jiao Tong University School of Medicine, 280 South Chongqing Road, Shanghai 200025, China.

Department of Neurological Surgery, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, 1630 Dongfang Road, Shanghai 200127, China.

出版信息

Nat Commun. 2017 May 10;8:15144. doi: 10.1038/ncomms15144.

DOI:10.1038/ncomms15144
PMID:28489075
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5436231/
Abstract

Hyperactivated Ras regulates many oncogenic pathways in several malignant human cancers including glioblastoma and it is an attractive target for cancer therapies. Ras activation in cancer cells drives protein internalization via macropinocytosis as a key nutrient-gaining process. By utilizing this unique endocytosis pathway, here we create a biologically inspired nanostructure that can induce cancer cells to 'drink drugs' for targeting activating transcription factor-5 (ATF5), an overexpressed anti-apoptotic transcription factor in glioblastoma. Apolipoprotein E3-reconstituted high-density lipoprotein is used to encapsulate the siRNA-loaded calcium phosphate core and facilitate it to penetrate the blood-brain barrier, thus targeting the glioblastoma cells in a macropinocytosis-dependent manner. The nanostructure carrying ATF5 siRNA exerts remarkable RNA-interfering efficiency, increases glioblastoma cell apoptosis and inhibits tumour cell growth both in vitro and in xenograft tumour models. This strategy of targeting the macropinocytosis caused by Ras activation provides a nanoparticle-based approach for precision therapy in glioblastoma and other Ras-activated cancers.

摘要

高活性 Ras 调节多种人类恶性肿瘤中的致癌途径,包括神经胶质瘤,是癌症治疗的一个有吸引力的靶点。癌细胞中的 Ras 激活通过巨胞饮作用驱动蛋白质内化,这是一种关键的营养获取过程。通过利用这种独特的内吞途径,我们在这里创建了一种受生物启发的纳米结构,它可以诱导癌细胞“喝药”,以靶向激活转录因子-5(ATF5),这是神经胶质瘤中过度表达的抗细胞凋亡转录因子。载有 siRNA 的载脂蛋白 E3 重构的高密度脂蛋白被用来包裹负载钙磷核心的 siRNA,并促进其穿透血脑屏障,从而以巨胞饮作用依赖的方式靶向神经胶质瘤细胞。携带 ATF5 siRNA 的纳米结构在体外和异种移植肿瘤模型中均表现出显著的 RNA 干扰效率,增加神经胶质瘤细胞凋亡并抑制肿瘤细胞生长。这种针对 Ras 激活引起的巨胞饮作用的靶向策略为神经胶质瘤和其他 Ras 激活型癌症的精准治疗提供了一种基于纳米颗粒的方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8eda/5436231/98b3db1f9b32/ncomms15144-f10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8eda/5436231/75f8142ed8d4/ncomms15144-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8eda/5436231/8eef869644e9/ncomms15144-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8eda/5436231/1c22b06899f1/ncomms15144-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8eda/5436231/7f9bbfd9e774/ncomms15144-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8eda/5436231/b7915900ec15/ncomms15144-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8eda/5436231/5c487e259bfb/ncomms15144-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8eda/5436231/9856b575d237/ncomms15144-f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8eda/5436231/87096ea6e5c4/ncomms15144-f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8eda/5436231/35ba05cd1b79/ncomms15144-f9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8eda/5436231/98b3db1f9b32/ncomms15144-f10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8eda/5436231/75f8142ed8d4/ncomms15144-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8eda/5436231/8eef869644e9/ncomms15144-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8eda/5436231/1c22b06899f1/ncomms15144-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8eda/5436231/7f9bbfd9e774/ncomms15144-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8eda/5436231/b7915900ec15/ncomms15144-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8eda/5436231/5c487e259bfb/ncomms15144-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8eda/5436231/9856b575d237/ncomms15144-f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8eda/5436231/87096ea6e5c4/ncomms15144-f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8eda/5436231/35ba05cd1b79/ncomms15144-f9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8eda/5436231/98b3db1f9b32/ncomms15144-f10.jpg

相似文献

1
Lipoprotein-biomimetic nanostructure enables efficient targeting delivery of siRNA to Ras-activated glioblastoma cells via macropinocytosis.脂蛋白仿生纳米结构通过巨胞饮作用实现 siRNA 对 Ras 激活的神经胶质瘤细胞的高效靶向递送。
Nat Commun. 2017 May 10;8:15144. doi: 10.1038/ncomms15144.
2
RNA nanoparticle as a vector for targeted siRNA delivery into glioblastoma mouse model.RNA纳米颗粒作为将靶向性小干扰RNA递送至胶质母细胞瘤小鼠模型的载体。
Oncotarget. 2015 Jun 20;6(17):14766-76. doi: 10.18632/oncotarget.3632.
3
A tumor-targeting cRGD-EGFR siRNA conjugate and its anti-tumor effect on glioblastoma in vitro and in vivo.一种肿瘤靶向性cRGD-EGFR siRNA偶联物及其对胶质母细胞瘤的体内外抗肿瘤作用
Drug Deliv. 2017 Nov;24(1):471-481. doi: 10.1080/10717544.2016.1267821.
4
RNA interference-mediated gene silencing of pleiotrophin through polyethylenimine-complexed small interfering RNAs in vivo exerts antitumoral effects in glioblastoma xenografts.通过聚乙烯亚胺复合小干扰RNA在体内对多效生长因子进行RNA干扰介导的基因沉默,可对胶质母细胞瘤异种移植瘤发挥抗肿瘤作用。
Hum Gene Ther. 2006 Jul;17(7):751-66. doi: 10.1089/hum.2006.17.751.
5
Cyclodextrin-Based Nanostructure Efficiently Delivers siRNA to Glioblastoma Cells Preferentially via Macropinocytosis.基于环糊精的纳米结构通过巨胞饮作用有效地将 siRNA 递送至神经胶质瘤细胞。
Int J Mol Sci. 2020 Dec 6;21(23):9306. doi: 10.3390/ijms21239306.
6
Development of siRNA-loaded chitosan nanoparticles targeting Galectin-1 for the treatment of glioblastoma multiforme via intranasal administration.载 Galectin-1 靶向 siRNA 的壳聚糖纳米粒经鼻腔给药治疗多形性胶质母细胞瘤的研究。
J Control Release. 2016 Apr 10;227:71-81. doi: 10.1016/j.jconrel.2016.02.032. Epub 2016 Feb 21.
7
Induction of in vivo synthetic lethal RNAi responses to treat glioblastoma.诱导体内合成致死 RNAi 反应治疗神经胶质瘤。
Cancer Biol Ther. 2009 Dec;8(23):2306-13. doi: 10.4161/cbt.8.23.10271. Epub 2009 Dec 7.
8
Catabolic pathways regulated by mTORC1 are pivotal for survival and growth of cancer cells expressing mutant Ras.由mTORC1调控的分解代谢途径对于表达突变型Ras的癌细胞的存活和生长至关重要。
Oncotarget. 2015 Dec 1;6(38):40405-17. doi: 10.18632/oncotarget.6334.
9
A recombinantly tailored β-defensin that displays intensive macropinocytosis-mediated uptake exerting potent efficacy against K-Ras mutant pancreatic cancer.一种经重组定制的β-防御素,其表现出强烈的巨胞饮作用介导的摄取,对K-Ras突变型胰腺癌具有强大疗效。
Oncotarget. 2016 Sep 6;7(36):58418-58434. doi: 10.18632/oncotarget.11170.
10
Charge Conversional Biomimetic Nanocomplexes as a Multifunctional Platform for Boosting Orthotopic Glioblastoma RNAi Therapy.电荷转换仿生纳米复合物作为一种多功能平台,用于增强原位脑胶质瘤 RNAi 治疗。
Nano Lett. 2020 Mar 11;20(3):1637-1646. doi: 10.1021/acs.nanolett.9b04683. Epub 2020 Feb 7.

引用本文的文献

1
Macropinocytosis: Both a Target and a Tool for Cancer Therapy.巨吞饮作用:既是癌症治疗的靶点又是工具
Biomolecules. 2025 Jun 26;15(7):936. doi: 10.3390/biom15070936.
2
Prognostic and immunological role of RHEBL1 in pan-cancer: a target for survival and immunotherapy.RHEBL1在泛癌中的预后和免疫作用:生存与免疫治疗的靶点
Discov Oncol. 2025 May 14;16(1):766. doi: 10.1007/s12672-025-02544-w.
3
Overcoming the Blood-Brain Barrier: Multifunctional Nanomaterial-Based Strategies for Targeted Drug Delivery in Neurological Disorders.

本文引用的文献

1
Targeting specific cells in the brain with nanomedicines for CNS therapies.利用纳米药物靶向大脑中的特定细胞用于中枢神经系统治疗。
J Control Release. 2016 Oct 28;240:212-226. doi: 10.1016/j.jconrel.2015.12.013. Epub 2015 Dec 11.
2
Inhibition of SHP2-mediated dephosphorylation of Ras suppresses oncogenesis.抑制SHP2介导的Ras去磷酸化可抑制肿瘤发生。
Nat Commun. 2015 Nov 30;6:8859. doi: 10.1038/ncomms9859.
3
GM1-Modified Lipoprotein-like Nanoparticle: Multifunctional Nanoplatform for the Combination Therapy of Alzheimer's Disease.
突破血脑屏障:基于多功能纳米材料的神经疾病靶向药物递送策略
Small Sci. 2024 Oct 6;4(12):2400232. doi: 10.1002/smsc.202400232. eCollection 2024 Dec.
4
Recombinant high-density lipoprotein targeted delivery of celastrol to promote foam cells lipophagy against early atherosclerosis.重组高密度脂蛋白靶向递送雷公藤红素以促进泡沫细胞自噬对抗早期动脉粥样硬化。
J Nanobiotechnology. 2025 Mar 22;23(1):237. doi: 10.1186/s12951-025-03327-9.
5
Brain-targeting drug delivery systems: The state of the art in treatment of glioblastoma.脑靶向给药系统:胶质母细胞瘤治疗的现状
Mater Today Bio. 2025 Jan 3;30:101443. doi: 10.1016/j.mtbio.2025.101443. eCollection 2025 Feb.
6
Improving PD-1 blockade plus chemotherapy for complete remission of lung cancer by nanoPDLIM2.通过纳米PDLIM2改善PD-1阻断联合化疗实现肺癌完全缓解
Elife. 2024 Dec 24;12:RP89638. doi: 10.7554/eLife.89638.
7
Temperature induces brain-intake shift of recombinant high-density lipoprotein after traumatic brain injury.创伤性脑损伤后,温度诱导重组高密度脂蛋白的脑摄取转移。
J Nanobiotechnology. 2024 Dec 19;22(1):769. doi: 10.1186/s12951-024-03016-z.
8
Targeting the undruggable in glioblastoma using nano-based intracellular drug delivery.利用基于纳米的细胞内药物递送靶向治疗胶质母细胞瘤中的不可成药靶点。
Med Oncol. 2024 Oct 29;41(12):303. doi: 10.1007/s12032-024-02546-8.
9
Role of size, surface charge, and PEGylated lipids of lipid nanoparticles (LNPs) on intramuscular delivery of mRNA.脂质纳米粒(LNPs)的大小、表面电荷和聚乙二醇化脂质在 mRNA 肌肉内递送中的作用。
J Nanobiotechnology. 2024 Sep 11;22(1):553. doi: 10.1186/s12951-024-02812-x.
10
Biorobotic Drug Delivery for Biomedical Applications.生物机器人药物输送在生物医学中的应用
Molecules. 2024 Aug 2;29(15):3663. doi: 10.3390/molecules29153663.
GM1-修饰脂蛋白样纳米颗粒:用于阿尔茨海默病联合治疗的多功能纳米平台。
ACS Nano. 2015 Nov 24;9(11):10801-16. doi: 10.1021/acsnano.5b03124. Epub 2015 Oct 12.
4
Design of a platform technology for systemic delivery of siRNA to tumours using rolling circle transcription.利用滚环转录设计一种用于将小干扰RNA全身性递送至肿瘤的平台技术。
Nat Commun. 2015 Aug 6;6:7930. doi: 10.1038/ncomms8930.
5
Active macropinocytosis induction by stimulation of epidermal growth factor receptor and oncogenic Ras expression potentiates cellular uptake efficacy of exosomes.通过刺激表皮生长因子受体和致癌性Ras表达来诱导活跃的巨胞饮作用可增强外泌体的细胞摄取效率。
Sci Rep. 2015 Jun 3;5:10300. doi: 10.1038/srep10300.
6
Metabolic Dependencies in RAS-Driven Cancers.RAS驱动型癌症中的代谢依赖性
Clin Cancer Res. 2015 Apr 15;21(8):1828-34. doi: 10.1158/1078-0432.CCR-14-2425.
7
Targeting RAS Membrane Association: Back to the Future for Anti-RAS Drug Discovery?靶向RAS膜结合:抗RAS药物研发回归未来?
Clin Cancer Res. 2015 Apr 15;21(8):1819-27. doi: 10.1158/1078-0432.CCR-14-3214.
8
Direct Attack on RAS: Intramolecular Communication and Mutation-Specific Effects.直接攻击 RAS:分子内通讯和突变特异性效应。
Clin Cancer Res. 2015 Apr 15;21(8):1810-8. doi: 10.1158/1078-0432.CCR-14-2148.
9
KRAS as a Therapeutic Target.KRAS作为一种治疗靶点。
Clin Cancer Res. 2015 Apr 15;21(8):1797-801. doi: 10.1158/1078-0432.CCR-14-2662.
10
Co-delivery of doxorubicin and siRNA for glioma therapy by a brain targeting system: angiopep-2-modified poly(lactic-co-glycolic acid) nanoparticles.通过脑靶向系统共递送阿霉素和小干扰RNA用于胶质瘤治疗:血管活性肠肽-2修饰的聚乳酸-羟基乙酸共聚物纳米粒
J Drug Target. 2015;23(9):832-46. doi: 10.3109/1061186X.2015.1025077. Epub 2015 Apr 9.